查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495952

乳房固定术市场 - 2024 年至 2029 年预测

Mastopexy Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

乳房固定术市场预计将从 2022 年的 14.66 亿美国成长到 2029 年的 22.93 亿美元，复合年增长率为 6.60%。

乳房固定术，也称为植入隆乳术，用于升高和塑造下垂的乳房，增加乳房丰满度，矫正下垂的乳头，改善乳房对称性。

为了增加乳房体积，治疗可以使用植入。如果乳房下垂是逐渐发生的，仅靠植入就可以透过一个小皮肤切口创造出年轻的外观。然而，任何切口都可能留下永久性疤痕。手术可以让你的乳房再次看起来年轻。

市场驱动因素：

  • 随着女性寻求更好的视觉吸引力，乳房固定术市场可能会扩大。

乳房固定术市场的成长是由于越来越多的女性寻求更好的视觉吸引力。为了改善手术并最大限度地提高消费者的福祉，乳房固定术行业的主要参与企业正在使用尖端设备。

此外，由于泰国、马来西亚和墨西哥等国家医疗旅游的增加，对美容隆乳治疗的需求也在增加。

  • 女性老年人口的增加正在推动市场成长。

预测期内推动乳房固定术市场成长的关键因素是老年女性数量的增加和对整容手术的渴望不断增长。根据美国人口普查局的数据，全球老年女性人数预计将从 2015 年的 36.01 亿增加到 2030 年的 41.39 亿。

乳房植入物的众多好处之一是提高自尊和对身体的认识。此外，由于分娩或体重减轻，40 岁以上的女性更有可能出现胸围较小、皮肤多余的情况。这一成长趋势的另一个原因是老年女性往往比许多年轻女性经济更稳定。

  • 对完全乳房固定术的需求不断增长也是推动市场的因素之一。

从收益来看，全乳房固定术预计将占据乳房固定术市场的大部分。当老年女性出现乳房下垂时，需要进行全乳房固定手术。在治疗过程中，医生经常切除恶性组织，并且可能需要进行乳房重建手术。

预计 Benelli Lollipop Lift 也将显着成长。垂直提升和垂直乳房固定术是两个不同的名称。垂直切口对于去除乳头旁边多余的皮肤非常有效。这种方法可以让您调整乳晕的形状。该技术重塑并收紧现有的自然组织，以创造更对称的轮廓。

  • 医疗旅游的激增正在推动市场成长。

推动乳房固定术市场成长的因素之一是医疗旅游业的兴起。在富裕国家，医疗保健费用是天文数字。儘管该手术被认为是昂贵的，但治疗方法被认为是高标准的。基本医疗用品的价格也相当高。无力在本国排队接受治疗的人可以出国就医，避免排队。因此，为了节省时间并避免病情恶化，许多人依靠医疗旅游并飞往国外，前往可以进行手术的国家。因此，政府的大力支持预计将促进乳房固定术市场的成长。

  • 乳房固定术市场的技术进步也是促成因素。

在生物科学领域的研究和开发中，人工智慧和机器学习技术的使用正在取得进展。我们支持新药的开发，改进临床试验，并分析大量的生物资料，以发现可以帮助我们更好地了解疾病和创造新疗法的模式。特别是，远端医疗、穿戴式科技和行动医疗应用程式正在经历数位健康技术的显着成长。这些创新实现了远端患者监控，改善了医疗保健的可近性，并使人们能够更好地控制自己的健康管理方式，从而加速乳房固定术市场的成长。

  • 由于医院乳房固定术的增加，乳房固定术变得普及。

医院预计将成为乳房固定术行业最大的收益来源。随着隆乳、丰胸等乳房手术的需求增加，医院为病患提供医疗服务的需求不断增加，支撑了乳房固定术市场的扩张。

例如，美学协会报告称，隆乳、乳房提升（乳房固定术）、乳房缩小术以及三者组合等乳房治疗增加了 48%。例如，2021 年进行了 365,000 例乳房植入手术。拉皮和其他脸部专科手术增加了 54%。

预计北美患者门户网站市场将蓬勃发展

预计北美在预测期内将占据最大的市场占有率。该地区最受欢迎的整容手术之一是隆乳手术。每年最常见的重组手术是切除皮肤癌或乳癌等肿瘤。

此外，由于人均医疗保健成本上升和美学标准提高，预计亚太地区将占据重要的市场占有率。女性健康意识的提高、医疗基础设施的扩大和生活方式的改变是影响该地区乳房固定术产业发展的一些关键因素。此外，中国和韩国等新兴经济体的整容手术普及不断上升，也刺激了乳房固定术市场的发展。

北美乳癌盛行率不断上升

预计在整个预测期内，美国将继续占据 Mastopexy 市场收益的最大份额。根据美国整形外科医师协会统计，自2000年以来，微创整容手术数量增加了200%以上，以创意和创新的方式塑造体形。

乳癌是美国最常见的癌症之一。 Breastcancer.org 估计，到 2022 年，八分之一的女性（约 13%）将在一生中罹患侵袭性乳癌。

市场的主要发展：

  • 2023 年 1 月，塑身衣和术后压缩衣设计和製造的先驱 The Marena Group 宣布推出突破性新技术，可显着改善乳房手术后患者的恢復情况。
  • 2022 年 6 月，CollPlant 宣布开始对其 3D 生物列印再生乳房植入计画进行大型动物研究。
  • 2022 年 5 月，GC Aesthetics 推出了革命性的乳头乳晕复合体 (NAC)重组植入。这种医疗设备使我们能够满足世界各地女性的临床需求。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行概述

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章乳房固定术市场：依技术分类

  • 介绍
  • 新月形乳房提升术
  • 贝内利电梯
  • 贝纳利棒棒糖升降机
  • 全乳房固定术

第六章乳房固定术市场：透过组织切口

  • 介绍
  • 皮肤
  • 胖的
  • 腺体的

第七章乳房固定术市场：依最终使用者分类

  • 介绍
  • 医院
  • 诊所
  • 其他的

第八章乳房固定术市场：按地区

  • 介绍
  • 北美洲
  • 南美洲
  • 欧洲
  • 中东/非洲
  • 亚太地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • The Esthetic Clinics
  • Aurora Clinics
  • Mayo Clinic
  • Spire Healthcare
  • Bupa
  • The Karri Clinic
  • Pristyn Care
  • Ramsay Health Care
  • Aprassa
  • Rebecca Ayers
简介目录
Product Code: KSI061616030

The mastopexy market is expected to grow at a CAGR of 6.60% from US$1.466 billion in 2022 to US$2.293 billion in 2029.

A mastopexy with breast augmentation, also known as a breast lift with implants, is a cosmetic surgery technique used to elevate and contour sagging breasts, increase breast fullness, realign drooping nipples, and enhance breast symmetry.

To augment the volume of the breast, the treatment may employ a breast implant. An implant alone can create a rejuvenated look with only a little skin incision when there is modest breast drooping. However, any incision can leave behind permanent scars. The surgery can give the breasts a younger-looking form again.

Market Drivers:

  • Opportunities for the mastopexy market to increase as women require better visual appeal.

The mastopexy market growth is due to women's increasing desire for better visual appeal. To improve surgeries and maximize consumer happiness, the major mastopexy industry participants have implemented cutting-edge equipment.

Additionally, the demand for cosmetic breast augmentation treatments is being increased by the rise in medical tourism to several nations, like Thailand, Malaysia, and Mexico.

  • The increasing female geriatric population drives the market's growth.

The main factors for the mastopexy market growth over the forecast period are the rise in the number of elderly women and their rising desire for cosmetic operations. According to the United Census Bureau, the number of elderly women worldwide is predicted to increase from 3,601 million in 2015 to 4,139 million by 2030.

One of the numerous advantages of getting breast augmentation surgery is that it improves one's self-esteem and perception of their body. In addition, women over 40 are more likely to lose volume in their breasts and have a lot of extra skin on them as a result of delivery or weight loss. This rising tendency is also influenced by the fact that older women tend to be more financially secure than many younger women.

  • The increasing need for full mastopexy is another factor that drives the market.

In terms of revenue, the full mastopexy method is anticipated to command the majority of the mastopexy market. When breast sagging occurs in elderly women, the full mastopexy operation is used. The doctors often remove malignant tissues during the treatment, which may necessitate breast reconstruction surgery.

The Benelli-lollipop lift is also predicted to see significant growth. Vertical lift and vertical mastopexy are other names for it. Incisions made vertically are very useful for removing extra skin that hangs down to the sides of the nipple. The areolas can be reshaped with this method. To create a more symmetrical contour, this technique reshapes and tightens the natural tissue that is already there.

  • The surge in medical tourism propels the market to grow.

One of the elements fueling the mastopexy market growth is the rise in medical tourism. The price of medical care is astronomical in wealthy nations. Although the procedures are regarded to be expensive, the therapies are thought to be of a high calibre. The cost of essential healthcare products is also rather high. People who cannot afford to stand in queue for treatment in their native country now have a method to avoid them by seeking care overseas. As a result, to save time and avoid making their medical conditions worse, many people rely on medical tourism and fly abroad to countries that provide immediate operations. Strong government support is thus anticipated to encourage mastopexy market growth.

  • Technological advancements in the mastopexy market are also a factor.

Research and development in the biological sciences are increasingly using AI and ML technology. They support the development of novel drugs, improve clinical trials, analyze enormous volumes of biological data, and find patterns that might help us better understand illnesses and create new treatments. In particular, telemedicine, wearable technology, and mobile health apps have all experienced tremendous growth in digital health technologies. These innovations make it possible to monitor patients remotely, improve access to healthcare, and give people greater control over how they manage their health which will upsurge the mastopexy market growth.

  • Increasing mastopexy procedures in hospitals makes it popular.

The mastopexy industry's largest revenue generator is anticipated to be the hospitals. The demand for hospitals to provide healthcare services to patients is rising along with the demand for breast surgery for breast augmentation and uplift, which supports the expansion of the mastopexy market.

For instance, the Aesthetic Society reported a 48% increase in breast treatments such as breast augmentation, breast lifts (mastopexies), breast reductions, and combinations of the three. For instance, in 2021, 365,000 breast augmentations were carried out. Facelifts and other specialized operations for the face saw a 54% increase.

The North American patient portal market is projected to propel

North America is predicted to have the largest market share during the forecast period. One of the most popular cosmetic surgery treatments in the area is breast augmentation. The most common reconstructive surgeries each year have been those to remove tumors, including those to remove skin and breast cancer among others.

Furthermore, Asia Pacific is anticipated to hold a significant market share due to rising healthcare costs per capita and rising aesthetic standards. Rising women's health awareness, expanding healthcare infrastructure, and shifting lifestyle trends are some of the major factors influencing the mastopexy industry development in the region. Additionally, the existence of nations with economies like China and Korea where the prevalence of cosmetic procedures is on the rise stimulates mastopexy market development.

Growing prevalence of breast cancer in North American region

The United States is anticipated to continue to provide the largest share of mastopexy market revenue throughout the forecast period. According to statistics from the American Society of Plastic Surgeons, inventive and novel methods of body shaping have been created, and the number of minimally invasive cosmetic procedures has increased by over 200 percent since 2000.

One of the most common cancers in the US is breast cancer. In 2022, Breastcancer.org estimated that 1 in 8 women (or around 13%) may get invasive breast cancer in their lifetime which will upsurge the mastopexy industry in the country.

Market Key Developments:

  • In January 2023, The Marena Group, a pioneer in the design and production of shapewear and post-surgery compression apparel, introduced a ground-breaking new technology that can significantly improve the patient's recovery from surgical breast treatments.
  • In June 2022, CollPlant announced the beginning of research in big animals for its 3D bioprinted regenerative breast implant program.
  • In May 2022, GC Aesthetics introduced the ground-breaking Nipple Areola Complex (NAC) reconstructive implant. The clinical requirements of women all over the world were addressed by this medical equipment.

Segmentation:

By Technique

  • Crescent Breast Lift
  • Benelli Lift
  • Benelli-Lollipop Lift
  • Full Mastopexy

By Tissue Incision

  • Skin
  • Adipose
  • Glandular

By End-User

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits for the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. MASTOPEXY MARKET, BY TECHNIQUE

  • 5.1. Introduction
  • 5.2. Crescent Breast Lift
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Benelli Lift
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Benelli Lollipop Lift
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Full Mastopexy
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness

6. MASTOPEXY MARKET, BY TISSUE INCISION

  • 6.1. Introduction
  • 6.2. Skin
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Adipose
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Glandular
    • 6.4.1. Market Trends and Opportunities
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. MASTOPEXY MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Clinics
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Others
    • 7.4.1. Market Trends and Opportunities
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. MASTOPEXY MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Technique
    • 8.2.2. By Tissue Incision
    • 8.2.3. By End-user
    • 8.2.4. By Country
      • 8.2.4.1. United States
        • 8.2.4.1.1. Market Trends and Opportunities
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Trends and Opportunities
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Trends and Opportunities
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Technique
    • 8.3.2. By Tissue Incision
    • 8.3.3. By End-user
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Trends and Opportunities
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Trends and Opportunities
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Trends and Opportunities
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Technique
    • 8.4.2. By Tissue Incision
    • 8.4.3. By End-user
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Trends and Opportunities
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Trends and Opportunities
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Trends and Opportunities
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Trends and Opportunities
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Trends and Opportunities
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Technique
    • 8.5.2. By Tissue Incision
    • 8.5.3. By End-user
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Trends and Opportunities
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Trends and Opportunities
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Trends and Opportunities
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Trends and Opportunities
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Technique
    • 8.6.2. By Tissue Incision
    • 8.6.3. By End-user
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Trends and Opportunities
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Trends and Opportunities
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Trends and Opportunities
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Trends and Opportunities
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Trends and Opportunities
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Trends and Opportunities
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Trends and Opportunities
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. The Esthetic Clinics
  • 10.2. Aurora Clinics
  • 10.3. Mayo Clinic
  • 10.4. Spire Healthcare
  • 10.5. Bupa
  • 10.6. The Karri Clinic
  • 10.7. Pristyn Care
  • 10.8. Ramsay Health Care
  • 10.9. Aprassa
  • 10.10. Rebecca Ayers